Tag
NATIONAL HEALTH SERVICE
The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients a promising 96.6% cure rate.
A drug named Crizanlizumab, produced by Novartis has been approved for Sickle Cell treatment in England by the...